抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
TMP269，98% | C25H21F3N4O3S | |||
|
|
|||||
|
Citarinostat，96% | C24H26ClN5O3 | |||
|
|
|||||
|
GSK503，99% | C31H38N6O2 | |||
|
|
|||||
|
GSK-J1，99% | C22H23N5O2 | |||
|
|
|||||
|
GSK-J4，98% | C24H27N5O2 | |||
|
|
|||||
|
BRD4770，99% | C25H23N3O3 | |||
|
|
|||||
|
EPZ-5676，99% | C30H42N8O3 | |||
|
|
|||||
|
G007-LK，99% | C25H16ClN7O3S | |||
|
|
|||||
|
Ro 31-8220 Mesylate，99% | C25H23N5O2S·CH4O3S | |||
|
|
|||||
|
MS436，98% | C18H17N5O3S | |||
|
|
|||||
|
PI-1840，98% | C22H26N4O3 | |||
|
|
|||||
|
GSK2879552，98% | C23H28N2O2 | |||
|
|
|||||
|
EPZ-6438，99% | C34H44N4O4 | |||
|
|
|||||
|
|
Nexturastat A，97% | C19H23N3O3 | |||
|
|
|||||
|
|
MM-102，≥98% | C35H49F2N7O4 | |||
|
|
|||||
|
LMK 235，99% | C15H22N2O4 | |||
|
|
|||||
|
|
Thiomyristoyl，98% | C34H51N3O3S | |||
|
|
|||||
|
ORY1001，98% | C15H24Cl2N2 | |||
|
|
|||||
|
BRD73954，98% | C16H16N2O3 | |||
|
|
|||||
